2017-03-22,Commit To Buy Idera Pharmaceuticals At $2, Earn 62.9% Annualized Using Options
2017-03-15,Idera Pharmaceuticals Reports Fourth Quarter And Year End 2016 Financial Results And Provides Corporate Update
2017-03-02,Idera To Present At The 37th Annual Cowen And Company Health Care Conference
2017-02-24,Idera Pharmaceuticals Presents Update From Ongoing Phase 1 Dose Escalation Clinical Trial Of Intratumoral IMO-2125 In Combination With Ipilimumab In Metastatic Melanoma Patients Refractory To Anti-PD-1 Treatment At The 2017 ASCO-SITC Clinical Immuno-Oncology Symposium
2017-02-06,Idera Announces Appointment Of Jonathan Yingling, Ph.D. As Senior Vice President Of Early Development
2017-01-26,Short Interest Decreases By 23% For IDRA
2017-01-04,Idera To Present At The 35th Annual J.P. Morgan Healthcare Conference
2016-11-28,Idera Pharmaceuticals And Vivelix Pharmaceuticals, Ltd. Enter Into Exclusive License Agreement For The Worldwide Rights To IMO-9200
2016-11-11,Idera Pharmaceuticals Reports Translational Data Supporting The Mechanism Of Action Of Intratumoral IMO-2125 From Ongoing Phase 1 Dose Escalation In Clinical Trial In Combination With Ipilimumab In Metastatic Melanoma Patients Refractory To Anti-PD-1 Treatment
2016-11-10,Idera To Present At The Stifel 2016 Healthcare Conference
2016-11-09,Idera Pharmaceuticals To Provide Multiple Presentations On Intratumoral IMO-2125 At The 2016 Society For Immunotherapy Of Cancer (SITC) Annual Meeting
2016-10-31,Tax-Loss Selling Offers Stock-Picking Opportunities
2016-10-28,Idera Pharmaceuticals Reports Third Quarter 2016 Financial Results
2016-10-14,5 Stocks Insiders Love Right Now
2016-10-07,Idera Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2016-10-05,Idera Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2016-09-27,Idera Pharmaceuticals Presents New Third Generation Antisense (3GA) Data At The 12th Annual Meeting Of The Oligonucleotide Therapeutics Society
2016-09-26,Idera Pharmaceuticals Reports Promising Data From Ongoing Phase 1 Dose Escalation In Clinical Trial Of Intra-tumoral IMO-2125 In Combination With Ipilimumab In Patients With PD-1 Refractory Metastatic Melanoma
2016-08-24,Idera Pharmaceuticals Presents The Novel Mechanism Of Action Of Its Third Generation Antisense Technology
2016-08-12,Idera To Present At The 2016 Wedbush PacGrow Healthcare Conference
2016-08-08,Commit To Buy Idera Pharmaceuticals At $1, Earn 18.9% Annualized Using Options
2016-08-02,Idera Pharmaceuticals Reports Second Quarter 2016 Financial Results And Provides Corporate Update
2016-06-07,Idera To Present At Two June Investor Healthcare Conferences
2016-05-09,Idera Pharmaceuticals Reports First Quarter 2016 Financial Results And Provides Corporate Update
2016-05-05,Idera To Release 2016 First Quarter Results On May 9, 2016
2016-04-19,Idera Presents Preclinical Data Demonstrating Enhanced Systemic Anti-Tumor Activity From Combination Treatment With Intra-tumoral IMO-2125 And IDO-1 Inhibitor At AACR Annual Meeting 2016
2016-04-11,Idera To Present At The 15th Annual Needham Healthcare Conference
2016-03-20,8 Biotech Stocks Under $10 Making Big Moves Higher
2016-03-10,Idera Pharmaceuticals Reports Fourth Quarter And Year End 2015 Financial Results And Provides Corporate Update
2016-03-03,Idera To Present At Two March Investor Healthcare Conferences
2016-01-29,5 Stocks Ready for Breakouts
2016-01-22,First Week of March 18th Options Trading For Idera Pharmaceuticals (IDRA)
2016-01-19,Trade-Ideas: Idera Pharmaceuticals (IDRA) Is Today's Weak On High Relative Volume Stock
2016-01-06,Idera Pharmaceuticals Announces Appointment Of Dr. Maxine Gowen To Its Board Of Directors
2016-01-05,Idera To Present At The 34th Annual J.P. Morgan Healthcare Conference
2015-12-14,Idera Pharmaceuticals Announces Initiation Of Phase 1/2 Clinical Trial Of Intra-tumoral IMO-2125 In Combination With Ipilimumab In Patients With Metastatic Melanoma
2015-12-09,Idera Pharmaceuticals (IDRA): Today's Weak On High Volume Stock
2015-12-08,5 Outperforming Stocks to Watch
2015-12-05,Idera Pharmaceuticals Reports Positive Data From Ongoing Phase 1/2 Clinical Trial Of IMO-8400 In Patients With Waldenstrom's Macroglobulinemia
2015-12-01,Today's Weak On High Volume Stock: Idera Pharmaceuticals (IDRA)
2015-11-30,Idera Pharmaceuticals Announces Several Key Leadership Additions
2015-11-24,Interesting IDRA Put And Call Options For January 2016
2015-11-23,Idera (IDRA) Stock Soars on GlaxoSmithKline Partnership
2015-11-23,Idera To Collaborate With GSK To Identify 3rd Generation Antisense Molecules For Treatment Of Renal Disease
2015-11-21,JPMorgan Likes These 5 Biotech Stocks
2015-11-18,Strong On High Relative Volume: Idera Pharmaceuticals (IDRA)
2015-11-18,Idera Announces Appointment Of Joanna Horobin As Chief Medical Officer
2015-11-09,Idera Pharmaceuticals Announces Initiation Of Phase 2 Clinical Trial Of IMO-8400 In Patients With Dermatomyositis
2015-11-06,Idera Pharmaceuticals Reports Third Quarter 2015 Financial Results And Provides Corporate Update
2015-11-05,Idera Pharmaceuticals Presents Preclinical Data Demonstrating Potent Anti-Tumor Response From Combination Treatment With Intra-Tumoral IMO-2125 And Anti-PD-1 Monoclonal Antibody At AACR-NCI-EORTC International Conference
2015-11-05,Idera Pharmaceuticals To Present Phase 1/2 IMO-8400 Clinical Data In Waldenstrom's Macroglobulinemia At The 2015 American Society Of Hematology Annual Meeting
2015-10-13,Short Interest Falls 32.2% For IDRA
2015-09-28,Have We Failed at a Retest?
2015-09-21,Idera Pharmaceuticals (IDRA) Weak On High Volume
2015-09-16,Idera Pharmaceuticals Presents New Intratumoral IMO-2125 Preclinical Data At CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference
2015-09-04,Idera To Present At The 22nd Annual NewsMakers In The Biotech Industry Conference
2015-08-31,Idera Pharmaceuticals (IDRA) Is Today's Strong On High Volume Stock
2015-08-07,Idera To Present At The 2015 Wedbush PacGrow Healthcare Conference
2015-08-06,Idera Pharmaceuticals Reports Second Quarter 2015 Financial Results And Provides Corporate Update
2015-07-23,6 Stocks Under $10 Triggering Breakout Trades
2015-07-23,Idera Pharmaceuticals (IDRA) Flagged As Strong On High Volume
2015-07-21,First Week Of September 18th Options Trading For Idera Pharmaceuticals (IDRA)
2015-07-06,Was This a Good Test of the Market Low?
2015-06-29,Idera Pharmaceuticals Announces Appointment Of Mark J. Casey As General Counsel And Secretary Of The Board Of Directors
2015-06-26,Short Interest In Idera Pharmaceuticals Increases 16%
2015-06-23,First Week Of February 2016 Options Trading For Idera Pharmaceuticals (IDRA)
2015-06-18,4 Breakout Biotech Stocks Under $10 to Watch
2015-06-15,Idera Phamaceuticals (IDRA) Stock Jumping Following New Coverage
2015-06-15,Analysts' Actions -- EMC, Lowe's, Micron and More
2015-06-11,I Still Don't Hear a Whoosh
2015-06-11,3 Stocks Under $10 Triggering Breakout Trades
2015-06-08,Idera Pharmaceuticals Enters Into A Strategic Clinical Research Alliance With MD Anderson Cancer Center To Advance Clinical Development Of Intratumoral TLR9 Agonist In Combination With Checkpoint Inhibitors
2015-06-01,Idera Pharmaceuticals (IDRA) Weak On High Volume Today
2015-05-28,What Is the TRIN Telling Us?
2015-05-27,Idera To Present At Two June Investor Healthcare Conferences
2015-05-19,First Week Of July 17th Options Trading For Idera Pharmaceuticals (IDRA)
2015-05-18,Strong On High Volume: Idera Pharmaceuticals (IDRA)
2015-05-18,Idera Pharmaceuticals Provides Development Update On IMO-9200, An Antagonist Of Toll-like Receptors
2015-05-11,Idera Pharmaceuticals (IDRA) Is Strong On High Volume Today
2015-05-11,Idera Pharmaceuticals Reports First Quarter 2015 Financial Results And Provides Corporate Update
2015-04-27,First Week Of IDRA June 19th Options Trading
2015-04-13,Idera To Present At The 14th Annual Needham Healthcare Conference
2015-04-01,Idera Pharmaceuticals (IDRA): Today's Weak On High Volume Stock
2015-04-01,Idera Announces FDA Orphan Drug Designation For IMO-8400 For The Treatment Of Diffuse Large B-Cell Lymphoma
2015-03-25,Interesting IDRA Put And Call Options For November 20th
2015-03-23,Idera Pharmaceuticals (IDRA) Weak On High Volume
2015-03-12,Idera Pharmaceuticals Reports Fourth Quarter And Year End 2014 Financial Results And Provides Corporate Update
2015-02-27,Idera Pharmaceuticals (IDRA) In A Perilous Reversal
2015-02-24,Interesting IDRA Call Options For April 17th
2015-02-23,Idera To Present At Two Upcoming Investor Healthcare Conferences
2015-02-19,Idera Pharmaceuticals Announces Closing Of Public Offering Of Common Stock
2015-02-17,One Reason Idera Pharmaceuticals (IDRA) Stock is Up Today
2015-02-13,Idera Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2015-02-09,Idera Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2015-01-26,Idera Announces Leadership Appointments
2015-01-09,Idera To Present At The 33rd Annual J.P. Morgan Healthcare Conference
2014-12-30,Idera Pharmaceuticals (IDRA) Is Strong On High Volume Today
2014-12-30,Idera Provides Key Updates On Clinical Development Of IMO-8400 For Treatment Of Waldenstrom's Macroglobulinemia
2014-12-29,Idera Pharmaceuticals (IDRA) Stock Surges After FDA Grants Orphan Designation for Cancer Treatment
2014-12-16,Idera Pharmaceuticals (IDRA) Marked As A Dead Cat Bounce Stock
2014-12-15,Idera Announces Several Key Additions To Management Team
2014-12-10,Idera Pharmaceuticals (IDRA) Is Weak On High Volume Today
2014-12-08,Idera Pharmaceuticals Presents Data Supporting IMO-8400 As Novel Therapy For Genetically Defined Forms Of B-Cell Lymphoma At Annual ASH Meeting
2014-12-04,First Week Of January 2015 Options Trading For Idera Pharmaceuticals (IDRA)
2014-12-02,Idera Pharmaceuticals Announces Cancer Immunotherapy Regimen With Intratumoral IMO-2055 Demonstrated Potent And Systemic Anti-Tumor Activity In Preclinical Models
2014-12-02,Idera Announces Appointment Of Robert A. Doody Jr. As Vice President Of Investor Relations And Corporate Communications
2014-12-02,Idera Pharmaceuticals To Present At The Piper Jaffray Healthcare Conference
2014-12-01,Idera Pharmaceuticals Names Vincent J. Milano Chief Executive Officer
2014-11-28,Idera Pharmaceuticals (IDRA) Is Today's Strong On High Volume Stock
2014-11-13,Idera Pharmaceuticals To Present At The Stifel 2014 Healthcare Conference
2014-11-07,Idera Pharmaceuticals Reports Third Quarter Financial Results And Announces Expansion Of Rare Disease Development Portfolio
2014-11-07,Idera Pharmaceuticals And Parent Project Muscular Dystrophy Announce Collaboration To Advance New Treatment Approach For Duchenne Muscular Dystrophy
2014-11-06,Idera Pharmaceuticals Announces Upcoming Presentations Of Data From Oncology Programs At Key Scientific Meetings
2014-10-29,Idera Pharmaceuticals To Announce Third Quarter 2014 Financial Results And Corporate Update On November 7, 2014
2014-10-14,Idera Pharmaceuticals Expands Pipeline By Initiating Clinical Development Of Proprietary TLR Antagonist Candidate IMO-9200
2014-08-22,4 Stocks Under $10 to Trade for Breakouts
2014-08-12,Idera Pharmaceuticals Reports Second Quarter 2014 Financial Results And Provides Corporate Update
2014-08-07,Idera Pharmaceuticals And The Myositis Association Join Forces To Advance The Clinical Development Of A Novel TLR Antagonist, IMO-8400, For The Treatment Of Myositis
2014-08-06,4 Under-$10 Stocks to Trade for Breakouts
2014-08-06,Idera Pharmaceuticals And Collaborators Publish Promising Preclinical Data Targeting MicroRNA With Gene Silencing Oligonucleotide Technology
2014-08-05,Idera Pharmaceuticals To Host Conference Call And Webcast To Report Second Quarter 2014 Financial Results
2014-07-28,Interesting IDRA Put And Call Options For September 20th
2014-06-27,Idera Pharmaceuticals To Be Added To The Russell 3000&#174; And Russell 2000&#174; Indexes
2014-06-25,First Week Of February 2015 Options Trading For Idera Pharmaceuticals (IDRA)
2014-06-23,5 Stocks Setting Up to Break Out
2014-06-17,Idera Pharmaceuticals To Participate In A Panel Discussion At The Piper Jaffray GenomeRx Symposium
2014-06-13,Idera Pharmaceuticals To Present At The Nucleic Acid Summit 2014
2014-05-28,Idera Pharmaceuticals To Present At The Jefferies 2014 Global Healthcare Conference
2014-05-21,First Week of July 19th Options Trading For Idera Pharmaceuticals (IDRA)
2014-05-13,Idera Pharmaceuticals Reports First Quarter 2014 Financial Results And Provides Update On Key Programs And Business Strategy
2014-05-08,Insider buying on the rise at these 5 stocks with earnings next week
2014-05-08,Idera Announces Agreement With Abbott To Develop A Companion Diagnostic For IMO-8400 In Genetically Defined Forms Of B-cell Lymphoma
2014-05-06,Idera Pharmaceuticals To Host Conference Call And Webcast To Report First Quarter 2014 Financial Results And Provide A Detailed Pipeline Review
2014-05-05,Idera Expands Management Team With Three Key Hires
2014-04-22,Will Idera Pharmaceuticals (IDRA) Stock Sustain Today's Rally?
2014-04-22,Interesting IDRA Put And Call Options For June 21st
2014-04-11,Today's Dead Cat Bounce Stock Is Idera Pharmaceuticals (IDRA)
2014-04-07,Idera Presents Preclinical Data At AACR Showing IMO-8400 Inhibits Tumor Growth And Survival Signaling In B-cell Lymphoma Cells With Oncogenic MYD88 L265P Mutation
2014-04-01,Idera Pharmaceuticals (IDRA) Marked As A Dead Cat Bounce Stock
2014-03-31,Today's Perilous Reversal Stock: Idera Pharmaceuticals (IDRA)
2014-03-28,Idera Pharmaceuticals Inc. Stock Downgraded (IDRA)
2014-03-28,Idera Pharmaceuticals (IDRA) Is Today's Pre-Market Mover With Heavy Volume Stock
2014-03-28,Idera Pharmaceuticals Announces Positive Top-line Data In Phase 2 Trial Of IMO-8400
2014-03-27,Ratings Changes Today
2014-03-26,First Week of November 22nd Options Trading For Idera Pharmaceuticals (IDRA)
2014-03-25,Today's Dead Cat Bounce Stock Is Idera Pharmaceuticals (IDRA)
2014-03-20,Insider buying is on the rise in these 4 rallying stocks
2014-03-13,Idera Pharmaceuticals Reports Fourth Quarter And Year End 2013 Financial Results And Provides Corporate Update
2014-03-13,Idera Pharmaceuticals Announces Expansion Of Pipeline Into Two Orphan Autoimmune Diseases
2014-03-12,Idera Pharmaceuticals Announces Appointment Of Julian Baker And Dr. Kelvin Neu To Its Board Of Directors
2014-03-06,Idera To Host Conference Call And Webcast To Report Fourth Quarter And Full Year 2013 Financial Results On Thursday, March 13, 2014
2014-02-26,Interesting IDRA Put And Call Options For April 19th
2014-02-26,Idera To Present At The Cowen &amp; Co. 34th Annual Health Care Conference
2014-02-24,Idera Pharmaceuticals (IDRA) Showing Signs Of Perilous Reversal Today
2014-02-18,Idera To Present At The 2014 RBC Capital Markets&#8217; Global Healthcare Conference
2014-02-10,Idera Pharmaceuticals Announces Closing Of Public Offering Of Common Stock And Pre-Funded Warrants
2014-02-07,2 Biotech Stocks Under $10 in Breakout Territory
2014-02-06,Idera To Present At 16th Annual BIO CEO &amp; Investor Conference
2014-02-05,Idera Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock And Pre-Funded Warrants
2014-02-04,Idera Pharmaceuticals Announces Public Offering Of Common Stock And Pre-Funded Warrants
2014-01-23,First Week Of IDRA March 22nd Options Trading
2014-01-23,Perilous Reversal Watch: Idera Pharmaceuticals (IDRA)
2014-01-22,Idera Announces Publication Of New Data Demonstrating Impact Of Inhibiting TLRs 7, 8, And 9 In A Preclinical Model Of Autoimmune Disease
2014-01-09,Today's Dead Cat Bounce Stock Is Idera Pharmaceuticals (IDRA)
2014-01-09,Idera Expands Leadership Team And Strengthens Clinical Development Expertise In Oncology And Orphan Diseases
2014-01-08,Perilous Reversal Watch: Idera Pharmaceuticals (IDRA)
2013-12-20,Ratings Changes Today
2013-12-12,5 Stocks Under $10 Set to Soar
2013-12-11,4 Health Care Stocks Under $10 to Watch
2013-12-04,Idera Pharmaceuticals Opens Enrollment For Phase 1/2 Clinical Trial Of IMO-8400 In Waldenstr&#246;m&#8217;s Macroglobulinemia
2013-11-25,Idera Pharmaceuticals To Present At The 25th Annual Piper Jaffray Healthcare Conference
2013-11-14,Idera Pharmaceuticals Reports Third Quarter 2013 Financial Results And Provides Corporate Update
2013-11-07,Idera Pharmaceuticals To Host Conference Call To Report Third Quarter 2013 Financial Results On Thursday, November 14, 2013
2013-09-30,Idera Pharmaceuticals Announces Closing Of Public Offering Of Common Stock And Pre-Funded Warrants
2013-09-25,Idera Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock And Pre-Funded Warrants
2013-09-24,Idera Pharmaceuticals Announces Public Offering Of Common Stock And Pre-Funded Warrants
2013-09-12,Idera To Provide Update On Programs At Stifel Nicolaus Healthcare Conference
2013-09-10,Idera To Present At The Stifel Nicolaus 2013 Healthcare Conference
2013-08-29,Idera Pharmaceuticals Enters Into Agreement With NCI To Evaluate Use Of TLR Antagonists For The Treatment Of Genetically Defined Lymphomas
2013-08-21,5 Stocks With Big Insider Buying
